0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Cholesterol transfer via endoplasmic reticulum contacts mediates lysosome damage repair

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Lysosome integrity is essential for cell viability, and lesions in lysosome membranes are repaired by the ESCRT machinery. Here, we describe an additional mechanism for lysosome repair that is activated independently of ESCRT recruitment. Lipidomic analyses showed increases in lysosomal phosphatidylserine and cholesterol after damage. Electron microscopy demonstrated that lysosomal membrane damage is rapidly followed by the formation of contacts with the endoplasmic reticulum (ER), which depends on the ER proteins VAPA/B. The cholesterol‐binding protein ORP1L was recruited to damaged lysosomes, accompanied by cholesterol accumulation by a mechanism that required VAP–ORP1L interactions. The PtdIns 4‐kinase PI4K2A rapidly produced PtdIns4P on lysosomes upon damage, and knockout of PI4K2A inhibited damage‐induced accumulation of ORP1L and cholesterol and led to the failure of lysosomal membrane repair. The cholesterol–PtdIns4P transporter OSBP was also recruited upon damage, and its depletion caused lysosomal accumulation of PtdIns4P and resulted in cell death. We conclude that ER contacts are activated on damaged lysosomes in parallel to ESCRTs to provide lipids for membrane repair, and that PtdIns4P generation and removal are central in this response.

          Abstract

          The cholesterol‐binding protein ORP1L mediates ESCRT‐independent lysosome damage repair via contact sites between lysosomes and the endoplasmic reticulum.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: not found

          Membrane lipids: where they are and how they behave.

          Throughout the biological world, a 30 A hydrophobic film typically delimits the environments that serve as the margin between life and death for individual cells. Biochemical and biophysical findings have provided a detailed model of the composition and structure of membranes, which includes levels of dynamic organization both across the lipid bilayer (lipid asymmetry) and in the lateral dimension (lipid domains) of membranes. How do cells apply anabolic and catabolic enzymes, translocases and transporters, plus the intrinsic physical phase behaviour of lipids and their interactions with membrane proteins, to create the unique compositions and multiple functionalities of their individual membranes?
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Lysosomes as dynamic regulators of cell and organismal homeostasis

            Exciting new discoveries have transformed the view of the lysosome from a static organelle dedicated to the disposal and recycling of cellular waste to a highly dynamic structure that mediates the adaptation of cell metabolism to environmental cues. Lysosome-mediated signalling pathways and transcription programmes are able to sense the status of cellular metabolism and control the switch between anabolism and catabolism by regulating lysosomal biogenesis and autophagy. The lysosome also extensively communicates with other cellular structures by exchanging content and information and by establishing membrane contact sites. It is now clear that lysosome positioning is a dynamically regulated process and a crucial determinant of lysosomal function. Finally, growing evidence indicates that the role of lysosomal dysfunction in human diseases goes beyond rare inherited diseases, such as lysosomal storage disorders, to include common neurodegenerative and metabolic diseases, as well as cancer. Together, these discoveries highlight the lysosome as a regulatory hub for cellular and organismal homeostasis, and an attractive therapeutic target for a broad variety of disease conditions.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Phosphoinositides: tiny lipids with giant impact on cell regulation.

              Phosphoinositides (PIs) make up only a small fraction of cellular phospholipids, yet they control almost all aspects of a cell's life and death. These lipids gained tremendous research interest as plasma membrane signaling molecules when discovered in the 1970s and 1980s. Research in the last 15 years has added a wide range of biological processes regulated by PIs, turning these lipids into one of the most universal signaling entities in eukaryotic cells. PIs control organelle biology by regulating vesicular trafficking, but they also modulate lipid distribution and metabolism via their close relationship with lipid transfer proteins. PIs regulate ion channels, pumps, and transporters and control both endocytic and exocytic processes. The nuclear phosphoinositides have grown from being an epiphenomenon to a research area of its own. As expected from such pleiotropic regulators, derangements of phosphoinositide metabolism are responsible for a number of human diseases ranging from rare genetic disorders to the most common ones such as cancer, obesity, and diabetes. Moreover, it is increasingly evident that a number of infectious agents hijack the PI regulatory systems of host cells for their intracellular movements, replication, and assembly. As a result, PI converting enzymes began to be noticed by pharmaceutical companies as potential therapeutic targets. This review is an attempt to give an overview of this enormous research field focusing on major developments in diverse areas of basic science linked to cellular physiology and disease.
                Bookmark

                Author and article information

                Contributors
                maja.radulovic@ous-research.no
                stenmark@ulrik.uio.no
                Journal
                EMBO J
                EMBO J
                10.1002/(ISSN)1460-2075
                EMBJ
                embojnl
                The EMBO Journal
                John Wiley and Sons Inc. (Hoboken )
                0261-4189
                1460-2075
                21 November 2022
                December 2022
                21 November 2022
                : 41
                : 24 ( doiID: 10.1002/embj.v41.24 )
                : e112677
                Affiliations
                [ 1 ] Centre for Cancer Cell Reprogramming, Faculty of Medicine University of Oslo Oslo Norway
                [ 2 ] Department of Molecular Cell Biology, Institute for Cancer Research Oslo University Hospital Oslo Norway
                [ 3 ] Cell Death and Metabolism, Center for Autophagy, Recycling and Disease Danish Cancer Society Research Center Copenhagen Denmark
                [ 4 ] Department of Molecular Medicine, Institute of Basic Medical Sciences University of Oslo Oslo Norway
                [ 5 ] Minerva Foundation Institute for Medical Research Biomedicum 2U Helsinki Finland
                [ 6 ] Department of Anatomy, Faculty of Medicine University of Helsinki Helsinki Finland
                [ 7 ] Department of Cellular and Molecular Medicine, Faculty of Health Sciences University of Copenhagen Copenhagen Denmark
                Author notes
                [*] [* ] Corresponding author. Tel: +47 22781491; E‐mail: maja.radulovic@ 123456ous-research.no

                Corresponding author. Tel: +47 22781818; E‐mail: stenmark@ 123456ulrik.uio.no

                Author information
                https://orcid.org/0000-0002-1322-3647
                https://orcid.org/0000-0001-5386-5022
                https://orcid.org/0000-0002-1922-2098
                https://orcid.org/0000-0001-5553-7997
                https://orcid.org/0000-0002-9803-1774
                https://orcid.org/0000-0001-5950-7111
                https://orcid.org/0000-0002-5406-5403
                https://orcid.org/0000-0002-1971-4252
                Article
                EMBJ2022112677
                10.15252/embj.2022112677
                9753466
                36408828
                af84e04f-13cf-4e5c-8ab2-7cc367729993
                © 2022 The Authors. Published under the terms of the CC BY NC ND 4.0 license.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 05 November 2022
                : 25 September 2022
                : 07 November 2022
                Page count
                Figures: 18, Tables: 0, Pages: 28, Words: 12339
                Funding
                Funded by: Danmarks Frie Forskningsfond (DFF)
                Award ID: 6108‐00542B
                Funded by: Danmarks Grundforskningsfond (DNRF) , doi 10.13039/501100001732;
                Award ID: DNRF125
                Funded by: EC ¦ European Research Council (ERC)
                Award ID: 788954
                Funded by: Kreftforeningen (NCS) , doi 10.13039/100008730;
                Award ID: 182698
                Award ID: 198140
                Funded by: Norges Forskningsråd (Forskningsrådet) , doi 10.13039/501100005416;
                Award ID: 302994
                Award ID: 262652
                Award ID: 325305
                Funded by: Novo Nordisk Fonden (NNF) , doi 10.13039/501100009708;
                Award ID: NNF17OC0029432
                Funded by: South‐Eastern Norway Regional Health Authority
                Award ID: 2016087
                Categories
                Article
                Articles
                Custom metadata
                2.0
                15 December 2022
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.2 mode:remove_FC converted:15.12.2022

                Molecular biology
                cholesterol,lysosome,membrane contact site,membrane repair,phosphoinositide,membranes & trafficking

                Comments

                Comment on this article